Bio-FD&C Co

Bio-FD&C Co EBIT Growth

The Year-over-Year EBIT Growth of Bio-FD&C Co (251120.KQ) as of Nov 13, 2026 is 28.85 %. In the previous year, Year-over-Year EBIT Growth was -3.60 % — a change of -900.64% (higher).

EBIT Growth

28.85 %

YoY

-900.64%

Last updated:

Year-over-Year EBIT Growth of Bio-FD&C Co is 2025 28.85 % . Year-over-Year EBIT Growth of Bio-FD&C Co was 2024 -3.60 % . It decreases by -900.64% higher compared to the previous year.

The Bio-FD&C Co EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2019
1,115.04 KRW
Jan 1, 2020
0.93 KRW
Jan 1, 2021
7.28 KRW
Jan 1, 2022
55.56 KRW
Jan 1, 2023
3.14 KRW
Jan 1, 2024
-3.60 KRW
Jan 1, 2025
28.85 KRW
The Bio-FD&C Co EBIT Growth history
YEAREBIT GrowthYoY
28.85 %-900.64%
-3.60 %-214.69%
3.14 %-94.34%
55.56 %+663.61%
7.28 %+682.04%
0.93 %-99.92%
1,115.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Year-over-Year EBIT Growth of Bio-FD&C Co is 28.85 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Bio-FD&C Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Bio-FD&C Co

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Bio-FD&C Co